Veterinary Vaccines Market 2018-2024
18-Jul-2018 | Number of pages: 184 | Report Id: BMRC HC 106 | Report Format: | Status: Upcoming

Veterinary Vaccines Market By Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Aquaculture Vaccine), By Disease (Porcine, Poultry, Livestock, Companion Animal, Aquaculture), Industry Analysis, Trends, and Forecast 2018 – 2024

 

Veterinary Vaccines Market : Growing awareness of animal health, Technological innovations and increasing incidence of zoonotic diseases transmitted through contaminated foodare some key drivers for Global Veterinary Vaccines Market.

Scope of Global Veterinary Vaccines Market Reports –

 Veterinary vaccines are used for improvement of immunity of animals by sanitizing animal health which avoids transmission of diseases fromboth domestic as well as wildlife animals to humans.Veterinary vaccines are the most productive product segment of focus for veterinary drug manufacturers.The vaccines can be administered intramuscularly i.e., into the muscleor subcutaneously i.e., under the skin to animal. Also the veterinary vaccines improve livestock production in a very cost effective manner. The mainpurpose of veterinary vaccines is to improve the health and welfare of pet animals, increase production of livestock in a cost-effective manner. The final fruitfulconclusion of vaccine research and development is the production of a product that will be available in the market or that will be used in the field to attain desired results.

The veterinary vaccines have been produced to kill the viral, bacterial, protozoal and multicellular pathogens. The continuouscollaboration between animals and human researchers and health experts will be of foremost importance for adapting new technologies, providing animal models of disease and challenging new and emerging infectious diseases.Generally, veterinary vaccines contain those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis and pinkeye. Many diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. An Economic damage due to death of livestock issubstantial as it affects the supply of dairy products, meat and other poultry products.

Veterinary biologics are governed by the U.S. Department of Agriculture (USDA) Center for Veterinary Biologics. To fight against growingoccurrence of possiblylethal veterinary diseases there is a significant rise in demand for combination vaccines that allow for higher accuracy and better stability of the finished product. Regulations are also concentrating on improving stability, consistency and quality of various animal vaccines. Maintaining the quality of production of veterinary vaccines will avoid risk of adverse effects.

Global Veterinary Vaccines Market has been segmented on the basis of Type, Disease, Technology and Geography. On the basis of Type Global Veterinary Vaccines Market is classified into Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Aquaculture Vaccine, Equine Vaccines, Pig Vaccines,Cattle Vaccines and others.On the basis of Disease Global Veterinary Vaccines Market is classified into Porcinedisease, Poultry disease, Livestock disease, Companion Animal disease, Aquaculture disease and others.On the basis of Technology Global Veterinary Vaccines Market is classified into inactivated vaccines, live attenuated vaccines, subunit vaccines, toxoid vaccines, recombinant vaccines, DNA vaccines,conjugate vaccinesand others.

The regions covered in Global Veterinary Vaccines Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Veterinary Vaccines Market Reports –

Global Veterinary Vaccines Market reports cover prominent players like Biogenesis Bago, Boehringer Ingelheim, CevaAnimal Health, Inc., China Animal Husbandry,  Hester, Hipra, IDT Biologika, Jinyu Bio-Technology, Merck Animal Health, Phibro Animal Health, Tianjin Ringpu, Vetoquinol, Virbac, Zoetis Inc.(Pfizer), Bayer Healthcare, Merial (Animal Health Division of Sanofi),Virbac, Bimeda Inc.,Eli Lily and Company, Indian Immunologicals Ltd.,Bioniche Animal Health, Brilliant Bio Pharma Ltd., Nisseiken Co., Ltd., C.A. Laboratorios Asociados (CALA), Dollvet,Avimex Animal Health, Zhaoqing Dahua Agriculture Bio-Pharm Co., Ltd.,Genera Inc., VETERINA Animal Health Ltd., INDOVAX Pvt. Ltd. and others.

Global Veterinary Vaccines Market Dynamics –

 Growing livestock population and increased acceptance of companion animals, increasingoccurrence of zoonotic diseases, initiatives by various government agencies, animal associations and leading players and the introduction of new types of vaccines are main key drivers that drives Global Veterinary Vaccines Market. Moreover, Growing Costs for the Storage of Vaccines and prevalence of chronic disease of animals arerestraints that hinder the growth of Global Veterinary Vaccines Market. Technological Revolution, growing awareness of Animal Health in Developing Countries,growing consumption of vegetarian food in major economies due to greater risk of obesity and other chronic disorders.  Similarly, rising demand for milk, eggs, meat & animal protein and would denote the considerable opportunity in forecast periodfor Global Veterinary Vaccines Market.

 Global Veterinary Vaccines Market Regional Analysis –

North America holds the largest market share for the Global Veterinary Vaccines Market in 2016 and is projected to remain constant throughout the forecast period. Increasing incidence of various animal diseases and adoption of vaccination for the same coupled with the rising pet population in the U.S. are some of the key factors contributing to the expansion of Global Veterinary Vaccines Market share of the region. Europe is the second largest market for Global Veterinary Vaccines Market after North America. Growing production of animal products, better-quality animal husbandry practices, higher pet population are boosting the growth of the Global Veterinary Vaccines Market in this region. Moreover cooperative initiatives of the government and private bodies to promote improved animal health are the factors propelling the acceptance of veterinary vaccines in Europe.

Asia-Pacific is likely to show the fastest growth rate during the forecast period. Predicted rise in the livestock population and the government initiatives especially in developing economies are some of the chief factors likely to improve the growth of Global Veterinary Vaccines Market in the region. The Global Veterinary Vaccines Market is driven by high Research & Development spending by many key players united with increasing attempts for commercialization of veterinary treatments at acceptably small prices.

Key Benefits for Global Veterinary Vaccines Market Reports –

  • Global Veterinary Vaccines Market report covers in depth historical and forecast analysis.
  • Global Veterinary Vaccines Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Veterinary Vaccines Market report helps to identify opportunities in market place.
  • Global Veterinary Vaccines Marketreport covers extensive analysis of emerging trends and competitive landscape.

Veterinary Vaccines Market Segmentation

By Type 

  • Porcine Vaccines
  • Poultry Vaccines
  • Livestock Vaccines
  • Companion Animal Vaccines
  • Aquaculture Vaccine
  • Equine Vaccines
  • Pig Vaccines
  • Cattle Vaccines
  • Other

By Disease 

  • Porcine disease
  • Poultry disease
  • Livestock disease
  • Companion Animal disease
  • Aquaculture disease
  • Other

By Technology 

  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • DNA Vaccines
  • Conjugate Vaccines
  • Others

By Region

  • North America
    • U.S.
    • Mexico
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
  • The Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Veterinary Vaccines Market Key Players

  • Biogenesis Bago
  • Boehringer Ingelheim
  • CevaAnimal Health, Inc.
  • China Animal Husbandry
  • Hester
  • Hipra
  • IDT Biologika
  • Jinyu Bio-Technology
  • Merck Animal Health
  • Phibro Animal Health

 

 

 

Table of Content

  1. Chapter – Report Methodology
    • Research Process
    • Primary Research
    • Secondary Research
    • Market Size Estimates
    • Data Triangulation
    • Forecast Model
    • USP’s of Report
    • Report Description
  2. Chapter – Global Veterinary Vaccines Market Overview: Qualitative Analysis
    • Market Introduction
    • Executive Summary
    • Global Veterinary Vaccines Market Classification
    • Market Drivers
    • Market Restraints
    • Market Opportunity
    • Global Veterinary Vaccines Market: Trends
    • Porter’s Five Forces Analysis
      • Bargaining Power of Suppliers
      • Bargaining Power of Consumers
      • Threat of New Entrants
      • Threat of Substitute Product and Services
      • Competitive Rivalry within the Industry
    • Market Attractiveness Analysis
      • Market Attractiveness Analysis by Segmentation
      • Market Attractiveness Analysis by Region
  1. Chapter – Global Veterinary Vaccines Market Overview: Quantitative Analysis
    • Global Veterinary Vaccines Market Production (K Unit), Market Share (%) and Growth Rate (%), 2014- 2024
    • Global Veterinary Vaccines Market Consumption (K Unit), Market Share ( %) and Growth Rate, 2014- 2024
    • Global Veterinary Vaccines Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2024
  2. Chapter –Global Veterinary Vaccines Market : by Type
  3. Chapter – Global Veterinary Vaccines Market : by Disease
  4. Chapter – Global Veterinary Vaccines Market : by Technology
  5. Chapter – Global Veterinary Vaccines Market : by Manufacturer
    • Global Veterinary Vaccines Market (USD Million), by Manufacturer, 2014 – 2024
    • Global Veterinary Vaccines Market Production (K Unit), by Manufacturer, 2014 – 2024
    • Global Veterinary Vaccines Market Consumption (K Unit), Manufacturer, 2014 – 2024
    • Global Veterinary Vaccines Market Share (%), by Manufacturer, 2017
    • Global Veterinary Vaccines Market Price (USD/Unit), by Manufacturer, 2014 – 2024
    • Global Veterinary Vaccines Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2024
    • Merger & Acquisition
    • Collaborations and Partnership
    • New Product Launch
  6. Chapter -Global Veterinary Vaccines Market: Regional Analysis
    • North America
    • North America Global Veterinary Vaccines Market Revenue (USD Million) and Growth Rate (%), 2014 – 2024.
    • North America Global Veterinary Vaccines Market Revenue (USD Million) By Country, 2014 – 2024.
    • North America Global Veterinary Vaccines Market Revenue Market Share (%) By Country, 2014 – 2024.
    • North America Global Veterinary Vaccines Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North America Global Veterinary Vaccines Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North AmericaGlobal Veterinary Vaccines Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  7. Chapter – Company Profiles
    • Avimex Animal Health
      • Overview
      • Financials
      • Product portfolio
      • Global Veterinary Vaccines Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
      • Global Veterinary Vaccines Market Share (%), 2014 – 2017
      • Business strategy
      • Recent developments
    • Bayer Healthcare
    • Bimeda Inc.
    • Biogenesis Bago
    • Bioniche Animal Health
    • Boehringer Ingelheim
    • Brilliant Bio Pharma Ltd.
    • A. Laboratorios Asociados (CALA)
    • Ceva Animal Health, Inc.
    • China Animal Husbandry
    • Dollvet
    • Eli Lily and Company
    • Genera Inc.
    • Hester
    • Hipra
    • IDT Biologika
    • Indian Immunologicals Ltd.
    • INDOVAX Pvt. Ltd.
    • Jinyu Bio-Technology
    • Merck Animal Health
    • Merial (Animal Health Division of Sanofi)
    • Nisseiken Co. Ltd.
    • Phibro Animal Health
    • Tianjin Ringpu
    • VETERINA Animal Health Ltd.
    • Vetoquinol
    • Virbac
    • Zhaoqing Dahua Agriculture Bio-Pharm Co. Ltd.
    • Zoetis Inc. (Pfizer)
    • Others
  8. Chapter – Market Research and Findings

 

 

  • Biogenesis Bago
  • Boehringer Ingelheim
  • CevaAnimal Health, Inc.
  • China Animal Husbandry
  • Hester
  • Hipra
  • IDT Biologika
  • Jinyu Bio-Technology
  • Merck Animal Health
  • Phibro Animal Health
  • Tianjin Ringpu
  • Vetoquinol
  • Virbac
  • Zoetis Inc.(Pfizer)
  • Bayer Healthcare
  • Merial (Animal Health Division of Sanofi)
  • Virbac
  • Bimeda Inc.
  • Eli Lily and Company
  • Indian Immunologicals Ltd.
  • Bioniche Animal Health
  • Brilliant Bio Pharma Ltd.
  • Nisseiken Co., Ltd.
  • C.A. Laboratorios Asociados (CALA)
  • Dollvet
  • Avimex Animal Health
  • Zhaoqing Dahua Agriculture Bio-Pharm Co., Ltd.
  • Genera Inc.,
  • VETERINA Animal Health Ltd.
  • INDOVAX Pvt. Ltd.
  • others